TuesdayFeb 27, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering

Lexaria, a global innovator in drug delivery platforms, just announced $3.6 million in gross proceeds from its registered direct offering priced at the market The proceeds will go to critical R&D studies, patent, and legal costs, as well as general working capital purposes This is timely, given Lexaria’s resolve to double down on GLP-1 investigations for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the registered direct offering for the purchase and sale of 1,558,443 shares of common stock at a purchase price of $2.31 – at the market under…

Continue Reading

MondayFeb 26, 2024 9:45 am

Amid Signs of New Real Estate Interest, Diamond Lake Minerals Inc. (DLMI) Builds Case for Fractional Investment Through STOs

Some high-profile investors and street-level market watchers are expressing faith that the real estate market is rebounding from last year’s slump, and are loading their money into key properties they believe have serious growth potential Utah-based Diamond Lake Minerals Inc. is creating a “powerful parent umbrella company” that pairs quality real world assets, such as real estate, with a digital “STO” asset, using the pairing as a means of inspiring confidence among those wary of involvement in the digital sector DLMI has teamed with U.S. Securities and Exchange Commission (“SEC”)-registered digital asset exchange INX to offer desired security in terms…

Continue Reading

MondayFeb 26, 2024 9:00 am

GEMXX Corp. (GEMZ) Gets Significant Boost for Achieving 2024 Gold, Ammolite Jewelry Goals

Las Vegas-based mine-to-jewelry maker GEMXX Corporation is reporting a 600 percent YOY jump in product delivery values for the month of January The company produces iridescent Ammolite jewelry that it obtains from its own gem mines in Alberta and gold mines in British Columbia, controlling each step in its production chain with no long-term debt GEMXX entered the gold market during the past year, enjoying the precious metal’s stability and record prices amid outside economic fluctuations GEMXX is working to improve its valuation, anticipating S-K 1300 technical reports on four assets will further improve the company’s balance sheet North American…

Continue Reading

ThursdayFeb 22, 2024 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Receives Initial Order for EV Cargo Vans to Open Caribbean Market

EV sales remain strong, projected to grow in 2024 Mullen is positioning itself in the global market with recent purchase order from Grupo Cavel in the Dominican Republic Mullen EVs “establish a new level of quality among commercial vehicles,” says Cavel CEO Electric vehicle sales are projected to continue growing globally in 2024, according to a recent NASDAQ report (https://ibn.fm/asZpm). That is great news for Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer that is expanding into the Caribbean market with its commercial CAMPUS EV cargo van (https://ibn.fm/Oph51). “It’s important to note that EV sales are expected to…

Continue Reading

WednesdayFeb 21, 2024 9:00 am

Diamond Lake Minerals Inc. (DLMI) Sees Fractional STO Ownership as a Solution to Real Estate Market Volatility and Insecurity

Utah-based Diamond Lake Minerals is developing its vision of an umbrella parent company that not only holds a variety of industry-crossing subsidiaries, but that also serves as a gateway for cautious investors looking to dip a toe into digital assets The company’s vertically integrated portfolio will include holdings that are infused with security token offerings registered with the U.S. Securities and Exchange Commission Diamond Lake views its digital asset-in-a-real world asset gateway as a hedge against market volatility, especially for real estate properties that may be over-leveraged and struggling to stay afloat while seeking favorable lending terms A recent spate…

Continue Reading

WednesdayFeb 21, 2024 8:50 am

GEMXX Corp. (GEMZ) to Capitalize on Growing Trend in India’s Jewelry and Colored Gemstone Markets

GEMXX recently announced insights into the burgeoning jewelry and colored gemstones markets in India The jewelry market in India is expected to grow by US$21.54 billion between 2023 and 2027, while the colored gemstones market is projected to reach $1.9 billion by 2033 from an estimated $707.8 million in 2024 GEMXX, a leading producer of top-quality finished Ammolite, anticipates that this rare gemstone has the potential to attract a significant portion of buyers in India seeking something innovative or distinct from conventional colored gemstones The company is positioned to capitalize on the growing trend in the colored gemstones market, with…

Continue Reading

TuesdayFeb 20, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Doubles Down on GLP-1 Clinical Studies for 2024; Terms 2023 as its Most Successful and Active Year of R&D

Lexaria, a global innovator in drug delivery platforms to enhance bioavailability, announced recently that it will focus on GLP-1 applications for diabetes and weight loss for the 2024 calendar year Chris Bunka, Lexaria’s CEO, has expressed his confidence in the company’s direction, reiterating the intention to demonstrate the superior performance of GLP-1 drugs processed with its patented DehydraTECH(TM) technology The company looks to build on the success of the early-stage results achieved in 2023, and looks to embark on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a…

Continue Reading

TuesdayFeb 20, 2024 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Displays Vehicles for First Time at CES, Unveils Newest EV Offering

Mullen debuted its FIVE RS at this year’s CES show in Las Vegas Several car and auto publications reported on the unveiling of the new model Mullen anticipates beginning production of the FIVE RS in late 2025, with sales commencing in mid-2026 For the first time ever, Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, exhibited its line of commercial and consumer EVs at the Consumer Electronics Show(R) (“CES”) in Las Vegas. In addition to displaying its line of vehicles, the company also debuted its high-performance EV crossover, the Mullen FIVE RS; the world debut of the new vehicle…

Continue Reading

FridayFeb 16, 2024 9:45 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Spotlighted in Article Touting Promising Boat Stocks

“In the dynamic world of investments, electric boat stocks are gaining momentum,” reports InvestorPlace The article calls Vision Marine a key player in the electric boat stocks market VMAR’s recent partnerships, market expansion and production enhancements point to potential growth and innovation As investors pay increasing attention to potential involvement in clean, green-energy companies, the idea of sustainability is becoming more of a priority in sectors across the board. Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator in the performance electric recreational boating industry, is capturing attention and was recently spotlighted in an InvestorPlace article titled “Three Electric…

Continue Reading

WednesdayFeb 14, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria, a global innovator in drug delivery platforms, just announced the submission of its IND application with the FDA for its HYPER-H23-1 phase 1b hypertension clinical trial This study will seek to evaluate the safety and tolerability of Lexaria’s patented DehydraTECH(TM) technology, specifically DehydraTECH-CBD, in hypertensive patients Lexaria expects to build on success of its previous studies, which showed positive results and DehydraTECH-CBD’s potential to have broad therapeutic utility Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”)…

Continue Reading

Contact us: (310) 299-1717